Over the last ten
years, global R&D spend has been steadily increasing, as has R&D spend
per new product; shareholders, anxious to see improved returns are putting
ever greater pressure on pharmaceutical businesses to deliver superior
earnings. Innovation is widely seen as holding the key, and lies at the heart
of a new value paradigm within the industry. But how precisely do you measure
innovation and the ROI it generates? What enables the pharmaceutical
industry's innovation leaders to outscore their competitors? What are the
drivers of innovation and how should they be exploited to plug gaps in the
R&D pipeline and restore or improve earnings growth.
Pharmaceutical
Innovation: An analysis of leading companies and strategies provides
a detailed analysis of the key strategic issues impacting on innovation in the
pharmaceutical and biotechnology industries. The report's findings draw from
comprehensive secondary and primary research, detailed case studies and
forward-looking analysis and insight.
Pharmaceutical
Innovation: An analysis of leading companies and strategies was
published by Reuters
Business Insight in July 2002
Table
of contents
Marketing
brochure
Independent Strategic Decision
Analysis